James Paul Kastenmayer insider trades

Open-market stock purchases and sales by James Paul Kastenmayer, General Counsel at ArriVent BioPharma, Inc, from SEC Form 4 filings since Jan 14, 2020.

Recent trades

DateStockTradeValue
Feb 2, 2026AVBP ArriVent BioPharma, IncBought (not open market)—

Companies traded

  • AVBP ArriVent BioPharma, Inc: other filings, last Feb 2, 2026
  • AGLE Aeglea BioTherapeutics, Inc: other filings, last Feb 23, 2023
  • VIE Viela Bio, Inc: other filings, last Mar 15, 2021

Get free alerts when James Paul Kastenmayer files a new trade →